GT200500224A - Proceso para la sìntesis de indoles n-alquilados c-2, c-3 sustituidos ùtiles como inhibidores de cpla2 - Google Patents

Proceso para la sìntesis de indoles n-alquilados c-2, c-3 sustituidos ùtiles como inhibidores de cpla2

Info

Publication number
GT200500224A
GT200500224A GT200500224A GT200500224A GT200500224A GT 200500224 A GT200500224 A GT 200500224A GT 200500224 A GT200500224 A GT 200500224A GT 200500224 A GT200500224 A GT 200500224A GT 200500224 A GT200500224 A GT 200500224A
Authority
GT
Guatemala
Prior art keywords
rented
indoles
synthesis
cpla2 inhibitors
useful substitutes
Prior art date
Application number
GT200500224A
Other languages
English (en)
Spanish (es)
Inventor
Ronald S Michalak
Mahmut Levent
Frederick J Vyverberg
Ara R Boyajian
Panolil Raveendranath
Michel Cantin
Alan Stockton
Michael W Winkley
Mousumi Ghosh
Christoph Dehnhardt
Charles Guinosso
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200500224A publication Critical patent/GT200500224A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GT200500224A 2004-08-19 2005-08-18 Proceso para la sìntesis de indoles n-alquilados c-2, c-3 sustituidos ùtiles como inhibidores de cpla2 GT200500224A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60312404P 2004-08-19 2004-08-19

Publications (1)

Publication Number Publication Date
GT200500224A true GT200500224A (es) 2006-03-21

Family

ID=35219553

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500224A GT200500224A (es) 2004-08-19 2005-08-18 Proceso para la sìntesis de indoles n-alquilados c-2, c-3 sustituidos ùtiles como inhibidores de cpla2

Country Status (24)

Country Link
US (3) US7582772B2 (cg-RX-API-DMAC10.html)
EP (1) EP1778629B1 (cg-RX-API-DMAC10.html)
JP (1) JP2008510707A (cg-RX-API-DMAC10.html)
KR (1) KR20070043036A (cg-RX-API-DMAC10.html)
CN (2) CN101830837A (cg-RX-API-DMAC10.html)
AR (1) AR053410A1 (cg-RX-API-DMAC10.html)
AT (1) ATE517084T1 (cg-RX-API-DMAC10.html)
AU (1) AU2005277392A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0514431A (cg-RX-API-DMAC10.html)
CA (1) CA2576008A1 (cg-RX-API-DMAC10.html)
CR (1) CR8936A (cg-RX-API-DMAC10.html)
EC (1) ECSP077244A (cg-RX-API-DMAC10.html)
GT (1) GT200500224A (cg-RX-API-DMAC10.html)
HN (1) HN2005000474A (cg-RX-API-DMAC10.html)
IL (1) IL181364A0 (cg-RX-API-DMAC10.html)
MX (1) MX2007002042A (cg-RX-API-DMAC10.html)
NO (1) NO20071253L (cg-RX-API-DMAC10.html)
PE (1) PE20060628A1 (cg-RX-API-DMAC10.html)
RU (1) RU2401829C2 (cg-RX-API-DMAC10.html)
SG (1) SG155214A1 (cg-RX-API-DMAC10.html)
SV (1) SV2006002200A (cg-RX-API-DMAC10.html)
TW (1) TW200609214A (cg-RX-API-DMAC10.html)
UA (1) UA85428C2 (cg-RX-API-DMAC10.html)
WO (1) WO2006023611A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
TW200718687A (en) * 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2
WO2008055148A2 (en) * 2006-10-31 2008-05-08 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
CL2007003143A1 (es) * 2006-10-31 2008-01-25 Wyeth Corp Composicion farmaceutica que comprende un compuesto derivado de indol y un sistema portador que comprende 10-50% de un primer solubilizante, 5-50% de un segundo solubilizante, 10-30% de un primer diluyente y 1-15% de un segundo diluyente; proceso de prepracion; y forma de dosificacion.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02115157A (ja) * 1988-10-24 1990-04-27 Hokko Chem Ind Co Ltd スルホニルグリシン誘導体および除草剤
UA81596C2 (en) * 1999-12-09 2008-01-25 Авентис Кропсаенс Гмбх Nitro-sulfobenzamides
US6984735B2 (en) * 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US7713964B2 (en) * 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US6797708B2 (en) * 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US7101875B2 (en) * 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
HUP0402577A3 (en) * 2001-12-03 2011-05-30 Wyeth Corp Indole derivatives as inhibitors of cytosolic phospholipase a2, process for producing them and pharmaceutical compositions containing them
US6635771B2 (en) * 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
TW200510305A (en) * 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
WO2005012235A1 (en) 2003-07-29 2005-02-10 Ciba Specialty Chemicals Holding Inc. 3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives
US7582771B2 (en) * 2003-09-03 2009-09-01 Wyeth Process for the synthesis of cPLA2 inhibitors
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) * 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles

Also Published As

Publication number Publication date
CN101006048B (zh) 2011-07-06
ECSP077244A (es) 2007-03-29
KR20070043036A (ko) 2007-04-24
JP2008510707A (ja) 2008-04-10
HN2005000474A (es) 2009-04-07
AR053410A1 (es) 2007-05-09
US20060041005A1 (en) 2006-02-23
TW200609214A (en) 2006-03-16
NO20071253L (no) 2007-05-15
AU2005277392A1 (en) 2006-03-02
CN101006048A (zh) 2007-07-25
US8034960B2 (en) 2011-10-11
EP1778629B1 (en) 2011-07-20
RU2401829C2 (ru) 2010-10-20
US7582772B2 (en) 2009-09-01
SG155214A1 (en) 2009-09-30
US20090306428A1 (en) 2009-12-10
ATE517084T1 (de) 2011-08-15
US7842837B2 (en) 2010-11-30
EP1778629A1 (en) 2007-05-02
PE20060628A1 (es) 2006-08-14
US20110054189A1 (en) 2011-03-03
UA85428C2 (ru) 2009-01-26
CN101830837A (zh) 2010-09-15
SV2006002200A (es) 2006-05-09
BRPI0514431A (pt) 2008-06-10
CR8936A (es) 2007-04-26
RU2007105231A (ru) 2008-09-27
IL181364A0 (en) 2007-07-04
CA2576008A1 (en) 2006-03-02
MX2007002042A (es) 2007-03-29
WO2006023611A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
CR20110286A (es) Proceso para la preparacion de derivados de l-alanina protegidos
DOP2009000039A (es) COMPUESTOS DE PIRIDO (2,3-D) PIRIMIDINONA Y SU USO COMO INHIBIDORES DE P13-Ka
CY1113131T1 (el) Τα παραγωγα ινδολης ως αγωνιστες υποδοχεων s1p1
ECSP099817A (es) Procesos para la preparacion de pirazoles
HRP20130800T1 (en) Opioid receptor modulators
CY1112102T1 (el) Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1
SV2010003472A (es) Compuestos de pirazol
ECSP10010195A (es) Derivados de indolinona y procedimiento para su fabricación
CR20110467A (es) Derivados de benzofuranilo como inhibidores de la glucoquinasa
EA201070912A1 (ru) Производные оксима в качестве ингибиторов hsp90
NI201000198A (es) Compuestos triazina como inhibidores mtor y quinasa p13.
CR20110279A (es) Derivados de piridina y pirimidina como inhibidores de fosfodiesterasa 10
ES2338590T3 (es) Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
SV2010003502A (es) Fungicidas novedosos
UY30146A1 (es) Radioligandos novedosos
CR10206A (es) Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
EA200702464A1 (ru) Способы получения фенольных 4-бифенилилазетидин-2-онов
ECSP088151A (es) Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
ECSP088251A (es) Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
ECSP077244A (es) Proceso para la síntesis de indoles n-alquilatados c-2, c-3 sustituidos útiles como inhibidores cpla2
CR20110075A (es) Agentes antifúngicos
EA200900943A1 (ru) Новый способ синтеза агомелатина
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
EA200900944A1 (ru) Новый способ получения кристаллической формы v агомелатина
UY31398A1 (es) Proceso para sintetizar compuestos de ácido fosfónico y posfínico